Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation
This study is currently recruiting participants.
Verified May 2012 by Staten Island University Hospital
Sponsor:
Staten Island University Hospital
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
Soad Bekheit, MD, Staten Island University Hospital
ClinicalTrials.gov Identifier:
NCT01590979
First received: April 27, 2012
Last updated: May 1, 2012
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2013 |
| Estimated Primary Completion Date: | April 2013 (Final data collection date for primary outcome measure) |